CALLA HEALTH FOUNDATION

Durham, NC · Medtech · Private

Injectable ethanol-polymer gel formulation with automated injector for cervical pre-cancer ablation in resource-limited settings

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Medtech
Headquarters: Durham, NC
Total capital: $4.7M

Federal grants: $4.7M; 7 awards · 2019–2025; Rank in peer group#170 of 538
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

Latest events

Jun 2025Federal grantHealth and Human S · Phase I · Development and validation of patient-ready Callascope for cervical imaging$317K
Jul 2024Federal grantHealth and Human S · Phase II · Optimizing ablation of cervical precancer with ethyl cellulose ethanol to enable translation to women in low and middle-income countries$913K
Sep 2023Federal grantHealth and Human S · Phase II · Optimizing ablation of cervical precancer with ethyl cellulose ethanol to enable translation to women in low and middle-income countries$910K
Jun 2023Federal grantHealth and Human S · Phase II · Innovations in cervical cancer diagnosis for low resource settings using advanced optical imaging and machine learning diagnostic algorithms.$996K
Jun 2022Federal grantHealth and Human S · Phase II · Innovations in cervical cancer diagnosis for low resource settings using advanced optical imaging and machine learning diagnostic algorithms.$998K
Sep 2020Federal grantHealth and Human S · Phase I · Optimizing delivery of ethyl cellulose ethanol for ablation of cervical precancer$300K
Sep 2019Federal grantHealth and Human S · Phase II · Innovations in cervical cancer diagnosis for low resource settings using advanced optical imaging and machine learning diagnostic algorithms.$300K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

Federal grants#170 · top 32%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

INSU HEALTH DESIGN, INC.Similar federal contract value in Medtech · null in contracts
QUALIA OTO, INC.Similar federal contract value in Medtech · null in contracts
Solius Labs, Inc.Similar federal contract value in Medtech · null in contracts
NEXGEN CANCER DETECTION LLCSimilar federal contract value in Medtech · null in contracts
Ting-Pau OeiSimilar federal contract value in Medtech · null in contracts
Arnoldware Applications LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.